Matt Fates

About

I am Chief Business Officer at Dyania Health, leading commercial operations and customer and partner engagement. I have worked with Dyania since 2022 as an investor, board member, close advisor and now CBO. The team, led by Eirini Schlosser, has built an incredible product that improves patient outcomes at scale and established strong partnerships with leading healthcare institutions. As AI begins to transform industry and society, I felt a strong pull to get more directly involved, operating at the forefront of driving positive change and using AI for good. For 25 years, I backed and worked with 100+ early and growth stage technology companies across four major tech and venture cycles: first at Norwest, then two decades at Ascent, and most recently five years at AI specialist Innospark, where I led the investment team. I continue as a Venture Partner with Innospark and advise Odaia Intelligence, Phaseshift, and KIPP MA at the board level. I have served on 20+ tech company boards and two nonprofit boards, advising CEOs and leadership teams on go-to-market, strategic milestones, fundraising preparation and process, building the executive bench, strategic partner negotiations, and M&A. My early career included BD, development, and product roles in early-stage healthtech, defensetech, and internet infrastructure, followed by tech investment banking. Prior investments and board/advisor roles include:• Broadband Access Systems (acquired by ADC Telecom)• Gold Wire Technology (acquired by Intelliden)• COSpace (acquired by InterNAP)• Cymfony (acquired by TNS)• Interactive Supercomputing (acquired by Microsoft)• Fidelis Security (acquired by General Dynamics)• StrikeIron (acquired by Informatica)• PerspecSys (acquired by Blue Coat Systems)• Connectbase (acquired by Equality Asset Management)

Experience

Education